Literature DB >> 31606352

Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?

Stefania Kiapidou1, Christina Liava1, Maria Kalogirou1, Evangelos Akriviadis1, Emmanouil Sinakos2.   

Abstract

The association of non-alcoholic fatty liver disease (NAFLD) with several other diseases has gained increased interest during the recent years. Among them, the association with chronic kidney disease (CKD) has emerged as an important one regarding both its prevalence and significance. The early recognition of this association is important for the prognosis of patients with NAFLD and CKD. Apart from early diagnosis, the accurate assessment of renal function is also crucial in the clinical practice of hepatologists. Several methods have been used in the literature for the evaluation of kidney function in patients with NAFLD up to now. In this respect, calculators (or formulas) for the estimation of Glomerular Filtration Rate (eGFR) and Albumin to Creatinine Ratio (ACR) are simple, practical and easily available methods for this purpose. The aim of this review is to report on the epidemiology and pathophysiology of the relationship between NAFLD and CKD and to describe the different methods of kidney function assessment in patients with NAFLD. The collection of all relevant data regarding this association will provide hepatologists with pertinent knowledge on this topic and allow them to use the most accurate methods for the assessment of kidney function in these patients in their clinical practice.
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Albumin to creatinine ratio; Chronic kidney disease; Estimated glomerular filtration rate; Kidney function markers; Non alcoholic fatty liver disease

Mesh:

Substances:

Year:  2019        PMID: 31606352     DOI: 10.1016/j.aohep.2019.07.013

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  9 in total

Review 1.  Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease.

Authors:  Nicholas W S Chew; Cheng Han Ng; Mark Dhinesh Muthiah; Arun J Sanyal
Journal:  Curr Atheroscler Rep       Date:  2022-05-04       Impact factor: 5.967

2.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

3.  Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study.

Authors:  Rajaa Nahra; Tao Wang; Kishore M Gadde; Jan Oscarsson; Michael Stumvoll; Lutz Jermutus; Boaz Hirshberg; Philip Ambery
Journal:  Diabetes Care       Date:  2021-05-20       Impact factor: 17.152

4.  Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study.

Authors:  Sandawana William Majoni; Federica Barzi; Wendy Hoy; Richard J MacIsaac; Alan Cass; Louise Maple-Brown; Jaquelyne T Hughes
Journal:  BMC Nephrol       Date:  2020-12-01       Impact factor: 2.388

Review 5.  Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease.

Authors:  Camelia Cojocariu; Ana-Maria Singeap; Irina Girleanu; Stefan Chiriac; Cristina M Muzica; Catalin Victor Sfarti; Tudor Cuciureanu; Laura Huiban; Carol Stanciu; Anca Trifan
Journal:  Can J Gastroenterol Hepatol       Date:  2020-12-29

Review 6.  Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.

Authors:  Mukut Sharma; Vikas Singh; Ram Sharma; Arnav Koul; Ellen T McCarthy; Virginia J Savin; Trupti Joshi; Tarak Srivastava
Journal:  Biomedicines       Date:  2022-02-09

7.  Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.

Authors:  Da Hea Seo; Young Ju Suh; Yongin Cho; Seong Hee Ahn; Seongha Seo; Seongbin Hong; Yong-Ho Lee; Young Ju Choi; Eunjig Lee; So Hun Kim
Journal:  Diabetes Metab J       Date:  2022-01-26       Impact factor: 5.893

8.  Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity.

Authors:  Sara De Nucci; Fabio Castellana; Roberta Zupo; Luisa Lampignano; Martina Di Chito; Roberta Rinaldi; Vito Giannuzzi; Raffaele Cozzolongo; Giuseppina Piazzolla; Gianluigi Giannelli; Rodolfo Sardone; Giovanni De Pergola
Journal:  Front Nutr       Date:  2022-09-08

9.  Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease.

Authors:  Xiaoyan Cai; Lichang Sun; Xiong Liu; Hailan Zhu; Yang Zhang; Sulin Zheng; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2021-06-23       Impact factor: 5.091

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.